Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-569,000
Closed -$20.7M 34
2023
Q4
$20.7M Buy
569,000
+249,000
+78% +$8.55M 4.63% 8
2023
Q3
$11.7M Sell
320,000
-110,000
-26% -$4.38M 3.11% 14
2023
Q2
$16.5M Buy
430,000
+240,000
+126% +$8.87M 4.4% 11
2023
Q1
$7.78M Buy
190,000
+98,000
+107% +$4.09M 1.94% 19
2022
Q4
$3.19M Buy
+92,000
New +$3.22M 0.96% 27

Other funds holding ADNT

EVR Research's ADNT Position: Q1 2024 in Review

EVR Research sold out of Adient (ADNT) in Q1 2024, closing a stake of 569,000 shares — an estimated $20.7M sold.

EVR Research first reported a position in ADNT in Q4 2022 and held it in 5 quarters. The position peaked at $20.7M in Q4 2023. 312 funds tracked by Wall St. Rank hold ADNT as of Q1 2024.

  • EVR Research reported no remaining Adient position as of Q1 2024 after selling out during the quarter.
  • EVR Research sold 569,000 Adient shares in Q1 2024, an estimated $20.7M.
  • EVR Research first reported a position in Adient in Q4 2022 and held it in 5 quarters.
  • EVR Research's Adient position peaked at $20.7M in Q4 2023.
  • 312 funds tracked by Wall St. Rank held Adient as of Q1 2024.

Based on EVR Research's 13F filing for Q1 2024, filed 15 May 2024.